Earnings History Data for Ginkgo Bioworks Holdings, Inc. (DNA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-08-2023	AH		DNA	Ginkgo Bioworks Holdings, Inc.	4,340	-0.09	-0.09	-0.41	Ginkgo Bioworks Holdings GAAP EPS of -$0.09 in-line, revenue of $81M beats by $9.48M [8/9/2023 5:03 PM]	1.75	-0.25 (-12.69%)	1.93	-0.08 (-3.99%)	1.12 - 4.91	45,350,761	21,000,000	546,199
Ginkgo Bioworks Holdings GAAP EPS of -$0.09 in-line, revenue of $81M beats by $9.48M [8/9/2023 5:03 PM] Ginkgo Bioworks cuts cell engineering revenue forecast, shares fall [8/10/2023 2:40 PM]
10-05-2023	AH	4:00 PM ET (May 10)	DNA	Ginkgo Bioworks Holdings, Inc.	2,840	-0.08	-0.09	-0.05	Ginkgo Bioworks Holdings GAAP EPS of -$0.11 misses by $0.02, revenue of $80.7M beats by $8.96M [5/10/2023 4:04 PM]	1.33	-0.02 (-1.11%)	1.27	-0.08 (-5.93%)	1.12 - 4.91	31,809,131	17,150,000	441,745
Ginkgo Bioworks Holdings GAAP EPS of -$0.11 misses by $0.02, revenue of $80.7M beats by $8.96M [5/10/2023 4:04 PM] Ginkgo downgraded at William Blair citing concerns on outlook [5/11/2023 10:51 AM]
01-03-2023	AH	4:00 PM ET (Mar 1)	DNA	Ginkgo Bioworks Holdings, Inc.	3,450	-0.04	-0.30	-0.01	Ginkgo Bioworks Holdings GAAP EPS of -$0.10 beats by $0.11, revenue of $98.28M beats by $9.41M [3/1/2023 4:04 PM]	1.39	-0.01 (-1.07%)	1.36	-0.04 (-2.86%)	1.29 - 4.91	23,993,310	21,790,000	206,748
Ginkgo Bioworks Holdings GAAP EPS of -$0.10 beats by $0.11, revenue of $98.28M beats by $9.41M [3/1/2023 4:04 PM]
14-11-2022	AH	4:00 PM ET (Nov 14)	DNA	Ginkgo Bioworks Holdings, Inc.	5,200	-0.40	-0.25	-0.07	Ginkgo Bioworks Holdings GAAP EPS of -$0.41 misses by $0.20, revenue of $66.4M beats by $5.97M [11/14/2022 4:04 PM]	2.67	-0.01 (-0.37%)	2.67	-0.01 (-0.37%)	2.09 - 14.20	40,526,825	22,530,000	996,835
Ginkgo Bioworks Holdings GAAP EPS of -$0.41 misses by $0.20, revenue of $66.4M beats by $5.97M [11/14/2022 4:04 PM] Ginkgo Bioworks down 7% as it sees fewer new cell programs, lower Foundry revenue range [11/14/2022 5:33 PM] Ginkgo Bioworks Reports Third Quarter 2022 Financial Results [Nov-14-22 04:01PM] Lygos and Ginkgo Bioworks Announce Partnership to Optimize Production of Biobased Specialty Chemicals [Nov-11-22 07:00AM]
15-08-2022	AH	4:00 PM ET (Aug 15)	DNA	Ginkgo Bioworks Holdings, Inc.	5,190	-0.41	-0.05	0.00	Ginkgo Bioworks Holdings GAAP EPS of -$0.41 misses by $0.27, revenue of $144.62M beats by $67.01M [8/15/2022 4:04 PM]	3.75	0.27 (7.59%)	4.18	0.69 (19.77%)	2.09 - 15.86	74,236,008	36,760,000	3,765,447
Ginkgo Bioworks Holdings GAAP EPS of -$0.41 misses by $0.27, revenue of $144.62M beats by $67.01M [8/15/2022 4:04 PM] Ginkgo Bioworks up 24% following upped full-year revenue guidance [8/15/2022 5:12 PM] Ginkgo extends gains with a 21% rise as Street reacts to Q2 results [8/16/2022 8:37 AM] Hot Stocks: HD, DNA climb on earnings news; ZM, SNOW fall on analyst downgrades [8/16/2022 12:33 PM] Ginkgo Bioworks and XpresCheck Receive Award to Expand CDCs Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports [Aug-15-22 09:00AM] Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports [Aug-15-22 08:49AM]
16-05-2022	AH	4:00 PM ET (May 16)	DNA	Ginkgo Bioworks Holdings, Inc.	4,220	-0.05	-0.04	0.00	Ginkgo Bioworks Holdings GAAP EPS of -$0.37 misses by $0.20, revenue of $168.4M beats by $62.73M [5/16/2022 4:03 PM]	2.75	0.32 (12.96%)	2.52	0.09 (3.70%)	2.09 - 15.86	33,546,922	24,960,000	172,963
Ginkgo Bioworks Holdings GAAP EPS of -$0.37 misses by $0.20, revenue of $168.4M beats by $62.73M [5/16/2022 4:03 PM] Ginkgo Bioworks sees quarterly net loss widen dramatically following jump in expenses [5/16/2022 5:36 PM] Ginkgo Bioworks Reports First Quarter 2022 Financial Results [May-16-22 04:01PM]
28-03-2022	AH	4:00 PM ET (Mar 28)	DNA	Ginkgo Bioworks Holdings, Inc.	6,220	-0.01	-0.05	0.00	Ginkgo Bioworks Holdings GAAP EPS of -$1.10 misses by $1.05, revenue of $148.49M beats by $53.63M [3/28/2022 4:06 PM]	4.55	0.81 (21.66%)	4.12	0.38 (10.16%)	2.62 - 15.86	58,247,392	25,700,000	647,954
Ginkgo Bioworks Holdings GAAP EPS of -$1.10 misses by $1.05, revenue of $148.49M beats by $53.63M [3/28/2022 4:06 PM] Ginkgo Bioworks sets better-than-expected guidance for 2022 after Q4 beat [3/28/2022 4:31 PM] Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-28-22 04:01PM] Ginkgo Bioworks looks past Covid tests for its next source of revenue [Mar-29-22 02:14PM]
15-11-2021	PM	8:05 AM ET (Nov 15)	DNA	Ginkgo Bioworks Holdings, Inc.	26,390	-0.07	-0.04	0.00	Ginkgo Bioworks Holdings reports Q3 results [11/15/2021 7:35 AM]	12.98	0.08 (0.62%)	13.21	0.31 (2.40%)	8.90 - 15.86	5,860,922	3,650,000	76,903
Ginkgo Bioworks Holdings reports Q3 results [11/15/2021 7:35 AM] Ginkgo Bioworks says it received inquiry from DOJ after short seller report [11/15/2021 8:40 AM] Ginkgo Bioworks Investor Alert [Nov-12-21 06:50PM] INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm [Nov-12-21 10:20AM] Joyn Bio expands Woodland ag-tech research operation [Nov-12-21 09:34AM] Ginkgo Bioworks Reports Third Quarter 2021 Results [Nov-15-21 07:30AM] INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm [Nov-15-21 09:30AM]